Effect of previous statin therapy on severity and outcome in ischemic stroke patients: A population-based study

Journal of Neurology

Volumn 260, Issue 1, 2013, Pages 30-37

  Aboa Eboulé, Corine ^a   Binquet, Christine ^b   Jacquin, Agnès ^a   Hervieu, Marie ^a   Bonithon Kopp, Claire ^b   Durier, Jérôme ^a   Giroud, Maurice ^a   Béjot, Yannick ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebral infarction; Epidemiology; Functional outcome; Registries; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; FEMALE; FRANCE; FUNCTIONAL ASSESSMENT; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COMMUNITY HEALTH PLANNING; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84872296782     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6580-9     Document Type: Article

References (30)

1. Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360:7-22
2. Amarenco P, Goldstein LB, Szarek M, Sillesen H, Rudolph AE, Callahan A 3rd, Hennerici M, Simunovic L, Zivin JA, Welch KM (2007) Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 38:3198-3204
3. Marti-Fabregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvis R, Cocho D, Roquer J, Rodriguez A, Garcia MD, Molina-Porcel L, Diaz-Manera J, Marti-Vilalta JL (2004) Favorable outcome of ischemic stroke in patients pretreated with statins. Stroke 35:1117-1121
4. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M (2005) HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 36:1298-1300
5. Arboix A, Garcia-Eroles L, Oliveres M, Targa C, Balcells M, Massons J (2010) Pretreatment with statins improves early outcome in patients with first-ever ischaemic stroke: a pleiotropic effect of statins or a beneficial effect of hypercholesterolemia? BMC Neurol 10:47
6. Deplanque D, Masse I, Lefebvre C, Libersa C, Leys D, Bordet R (2006) Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 67:1403-1410
7. Martinez-Sanchez P, Rivera-Ordonez C, Fuentes B, Ortega-Casarrubios MA, Idrovo L, Diez-Tejedor E (2009) The beneficial effect of statins treatment by stroke subtype. Eur J Neurol 16:127-133
8. Sacco S, Toni D, Bignamini AA, Zaninelli A, Gensini GF, Carolei A, Group SS (2011) Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol 26:133-139
9. Greisenegger S, Mullner M, Tentschert S, Lang W, Lalouschek W (2004) Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci 221:5-10
10. Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J, Davis L, Baird AE (2004) Rising statin use and effect on ischemic stroke outcome. BMC Med 2:4
11. Elkind MS, Flint AC, Sciacca RR, Sacco RL (2005) Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 65:253-258
12. Flint AC, Kamel H, Navi BB, Rao VA, Faigeles BS, Conell C, Klingman JG, Sidney S, Hills NK, Sorel M, Cullen SP, Johnston SC (2012) Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival. Stroke 43:147-154
13. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A (2008) Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 39:1779-1785
14. Goldstein LB, Amarenco P, Zivin J, Messig M, Altafullah I, Callahan A, Hennerici M, MacLeod MJ, Sillesen H, Zweifler R, Michael K, Welch A (2009) Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 40:3526-3531
15. Bushnell CD, Griffin J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, Harrington RA, White HD, Simes RJ, Califf RM, Topol EJ, Easton JD (2006) Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 37:1427-1431
16. Vauthey C, de Freitas GR, van Melle G, Devuyst G, Bogousslavsky J (2000) Better outcome after stroke with higher serum cholesterol levels. Neurology 54:1944-1949
17. Zuliani G, Cherubini A, Atti AR, Ble A, Vavalle C, Di Todaro F, Benedetti C, Volpato S, Marinescu MG, Senin U, Fellin R (2004) Low cholesterol levels are associated with short-term mortality in older patients with ischemic stroke. J Gerontol A Biol Sci Med Sci 59:293-297
18. Bejot Y, Osseby GV, Gremeaux V, Durier J, Rouaud O, Moreau T, Giroud M (2009) Changes in risk factors and preventive treatments by stroke subtypes over 20 years: a population-based study. J Neurol Sci 287:84-88
19. Meyer BC, Lyden PD (2009) The modified National Institutes of Health Stroke Scale: its time has come. Int J Stroke 4:267-273
20. den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW, Investigators P (2008) Correction: PAIS: paracetamol (acetaminophen) in stroke; protocol for a randomized, double blind clinical trial. [ISCRTN74418480]. BMC Cardiovasc Disord 8:29
21. Bosel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, Megow D, Dirnagl U, Hortnagl H, Fink KB, Endres M (2005) Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem 92:1386-1398
22. Kawashima S, Yamashita T, Miwa Y, Ozaki M, Namiki M, Hirase T, Inoue N, Hirata K, Yokoyama M (2003) HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 34:157-163
23. Ortego M, Bustos C, Hernandez-Presa MA, Tunon J, Diaz C, Hernandez G, Egido J (1999) Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 147:253-261
24. Chen J, Zhang ZG, Li Y, Wang Y, Wang L, Jiang H, Zhang C, Lu M, Katakowski M, Feldkamp CS, Chopp M (2003) Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. Ann Neurol 53:743-751
25. Laufs U, Gertz K, Huang P, Nickenig G, Bohm M, Dirnagl U, Endres M (2000) Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31:2442-2449
26. Asahi M, Huang Z, Thomas S, Yoshimura S, Sumii T, Mori T, Qiu J, Amin-Hanjani S, Huang PL, Liao JK, Lo EH, Moskowitz MA (2005) Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. J Cereb Blood Flow Metab 25:722-729
27. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK (1998) Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:8880-8885
28. Nicholas JS, Swearingen CJ, Thomas JC, Rumboldt Z, Tumminello P, Patel SJ (2008) The effect of statin pretreatment on infarct volume in ischemic stroke. Neuroepidemiology 31:48-56
29. Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW (2006) Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J Neuroimaging 16:341-346
30. Bath PM, Lees KR, Schellinger PD, Altman H, Bland M, Hogg C, Howard G, Saver JL, European Stroke Organisation Outcomes Working G (2012) Statistical analysis of the primary outcome in acute stroke trials. Stroke 43:1171-1178